Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma
Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
ViP is a double blinded clinical trial which will compare gemcitabine and vandetanib
chemotherapy with gemcitabine alone in patients with locally advanced or metastatic
pancreatic carcinoma.